135 related articles for article (PubMed ID: 1979501)
21. Two new nonsense mutations in type Ia antithrombin III deficiency at Leu 140 and Arg 197.
Tomonari A; Iwahana H; Yoshimoto K; Shigekiyo T; Saito S; Itakura M
Thromb Haemost; 1992 Oct; 68(4):455-9. PubMed ID: 1360174
[TBL] [Abstract][Full Text] [Related]
22. Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families.
van Boven HH; Olds RJ; Thein SL; Reitsma PH; Lane DA; Briët E; Vandenbroucke JP; Rosendaal FR
Blood; 1994 Dec; 84(12):4209-13. PubMed ID: 7994035
[TBL] [Abstract][Full Text] [Related]
23. Isolation of a cDNA clone for human antithrombin III.
Prochownik EV; Markham AF; Orkin SH
J Biol Chem; 1983 Jul; 258(13):8389-94. PubMed ID: 6305982
[TBL] [Abstract][Full Text] [Related]
24. Five antithrombin variants, four associated with thrombosis.
Fitton HL; Walker ID; Jones L; Brown K; Carrell RW; Coughlin P
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):145-8. PubMed ID: 9518046
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis for type 1 antithrombin deficiency: identification of two novel point mutations and evidence for a de novo splice site mutation.
Jochmans K; Lissens W; Yin T; Michiels JJ; van der Luit L; Peerlinck K; De Waele M; Liebaers I
Blood; 1994 Dec; 84(11):3742-8. PubMed ID: 7949130
[TBL] [Abstract][Full Text] [Related]
26. Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.
Picard V; Bura A; Emmerich J; Alhenc-Gelas M; Biron C; Houbouyan-Reveillard LL; Molho P; Labatide-Alanore A; Sié P; Toulon P; Verdy E; Aiach M
Br J Haematol; 2000 Sep; 110(3):731-4. PubMed ID: 10997988
[TBL] [Abstract][Full Text] [Related]
27. AT III Barcelona: a familial quantitative-qualitative AT III deficiency.
Grau E; Fontcuberta J; Félez J; de Diego I; Soto R; Rutllant ML
Thromb Haemost; 1988 Feb; 59(1):13-7. PubMed ID: 3363529
[TBL] [Abstract][Full Text] [Related]
28. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
Feussner G; Funke H; Weng W; Assmann G; Lackner KJ; Ziegler R
Eur J Clin Invest; 1992 Sep; 22(9):599-608. PubMed ID: 1360898
[TBL] [Abstract][Full Text] [Related]
29. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic survey of 16 kindreds with hereditary antithrombin III deficiency.
Bock SC; Prochownik EV
Blood; 1987 Nov; 70(5):1273-8. PubMed ID: 3663935
[TBL] [Abstract][Full Text] [Related]
31. A novel antithrombin gene mutation: slippage and mispairing as a mechanism of genetic disease.
Fitches AC; May SJ; Olds RJ
Pathology; 1996 Nov; 28(4):339-42. PubMed ID: 9007953
[TBL] [Abstract][Full Text] [Related]
32. De novo splice site mutation in the antithrombin III (AT3) gene causing recurrent venous thrombosis: demonstration of exon skipping by ectopic transcript analysis.
Berg LP; Grundy CB; Thomas F; Millar DS; Green PJ; Slomski R; Reiss J; Kakkar VV; Cooper DN
Genomics; 1992 Aug; 13(4):1359-61. PubMed ID: 1505975
[TBL] [Abstract][Full Text] [Related]
33. An overview of the mechanism of action of antithrombin and its inherited deficiency states.
Blajchman MA
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S5-11; discussion S59-64. PubMed ID: 8186357
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis.
Tomczak JA; Ando RA; Sobel HG; Bovill EG; Long GL
Thromb Res; 1994 May; 74(3):243-54. PubMed ID: 7913773
[TBL] [Abstract][Full Text] [Related]
35. Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency--partial/complete deletions and rearrangement of the antithrombin gene.
Beauchamp NJ; Makris M; Preston FE; Peake IR; Daly ME
Thromb Haemost; 2000 May; 83(5):715-21. PubMed ID: 10823268
[TBL] [Abstract][Full Text] [Related]
36. A novel SERPINC1 frameshift mutation in two antithrombin deficiency families.
Zhang D; Sun B; Zhang X; Li H; Lin Y; Qin L; Chen L; Zhang L; Ru K; Yang R
Int J Lab Hematol; 2020 Apr; 42(2):e48-e51. PubMed ID: 31441586
[No Abstract] [Full Text] [Related]
37. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine.
Gandrille S; Aiach M; Lane DA; Vidaud D; Molho-Sabatier P; Caso R; de Moerloose P; Fiessinger JN; Clauser E
J Biol Chem; 1990 Nov; 265(31):18997-9001. PubMed ID: 2229057
[TBL] [Abstract][Full Text] [Related]
38. The confirmation of preclinical familial antithrombin deficiency using polymorphism and specific oligonucleotide probes .
Beresford CH; Hughes PM; Olds R
N Z Med J; 1990 Jun; 103(892):296-8. PubMed ID: 1973278
[TBL] [Abstract][Full Text] [Related]
39. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
40. Two Novel Mutations Cause Hereditary Antithrombin Deficiency in a Chinese Family.
Zhang H; Liu S; Luo S; Jin Y; Yang L; Xie H; Pan J; Wang M
Acta Haematol; 2020; 143(3):260-265. PubMed ID: 31480053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
